GNRH1 and prostate carcinoma: In the early 1980s, LHRH agonists were introduced [3] in the endocrinological treatment of advanced prostate cancer, and the oncological outcomes of surgical castration by bilateral orchidectomy and medical castration by LHRH agonists are now generally regarded as the similar.